Engineered Lipidic Nanomaterials Inspired by Sphingomyelin Metabolism for Cancer Therapy

Han Zhu1, Hua-Jie Chen2, Hai-Yan Wen2

  • 1State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Center for Analytical Sciences, College of Chemistry, and School of Medicine, Nankai University, Tianjin 300071, China.

PubMed
Summary

Sphingomyelin (SM) metabolism influences cancer cell fate. Engineered lipid nanoparticles targeting SM pathways offer promising cancer therapy strategies, with ongoing research addressing challenges and future directions.